Question 1

What is LY2940680, and how does it work for my child's type of cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

Question 3

How will we monitor my child's progress during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if my child does not respond to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options available that we should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will we need to come in for visits and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma clinical trial (NCT01697514). Contact the study team or your healthcare provider for specific answers.

What this study is about